Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates

PURPOSE: ABT-888 inhibits poly(ADP-ribose) polymerase (PARP) and may enhance the efficacy of chemotherapy and radiation in CNS tumors. We studied the plasma and cerebrospinal fluid (CSF) pharmacokinetics (PK) of ABT-888 in a non-human primate (NHP) model that is highly predictive of human CSF penetr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Muscal, Jodi A., Thompson, Patrick A., Giranda, Vincent L., Dayton, Brian D., Bauch, Joy, Horton, Terzah, McGuffey, Leticia, Nuchtern, Jed G., Dauser, Robert C., Gibson, Brian W., Blaney, Susan M., Su, Jack M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2953793/
https://ncbi.nlm.nih.gov/pubmed/19526240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-009-1044-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia